PRINCETON, NJ -- (MARKET WIRE) -- January 31, 2007 -- PharmaTrials International, Inc., a subsidiary of New Life Scientific, Inc. (OTCBB: NWLS), specializes in providing clinical trial services, market research, and services to enable pharmaceutical, biotech and medical device companies worldwide to conduct research and to obtain regulatory approval of their products. PharmaTrials International, Inc. (PTI) today announced plans to expand its presence into Asia, and is currently exploring China and Indonesia, to optimize access to specific disease and treatment naïve populations in the region, and to effectively navigate country-specific regulatory and registration processes. PTI engaged the services of Raymond Y. Chin, as a consultant and advisor to PTI.
